Are insiders buying CLYM stock?

Yes — 2 distinct insiders have bought CLYM (Climb Bio, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 7, 2026.

How much CLYM stock have insiders bought?

Insiders have bought a combined $779.6K of CLYM across 3 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in CLYM?

A cluster buy is two or more distinct Climb Bio, Inc. insiders — officers, directors, or 10% owners — each buying CLYM on the open market within a rolling window. CLYM has 1 detected cluster buy to date.

Where does this CLYM insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

CLYM insider buying

1 cluster buy

Climb Bio, Inc. · Healthcare

When two or more insiders at Climb Bio, Inc. buy CLYM in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in CLYM plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$779.6K

Market cap

$759.9M

Detected clusters

Dec 11, 2025 – Jan 5, 2026
Detected Jan 5, 2026
2 insiders
Total bought
$779.6K
Market cap
$759.9M

All notable open-market buys in CLYM

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Jan 5, 2026	RA Capital Healthcare Fund LPcluster Director, 10% Owner	7,111	$3.50	$24.9K	SEC ↗
Dec 12, 2025	Kolchinsky Petercluster Director, 10% Owner	101,462	$2.86	$290.2K	SEC ↗
Dec 11, 2025	Kolchinsky Petercluster Director, 10% Owner	213,099	$2.18	$464.6K	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

CLYM insider buying — FAQ

Are insiders buying CLYM stock?: Yes — 2 distinct insiders have bought CLYM (Climb Bio, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 7, 2026.
How much CLYM stock have insiders bought?: Insiders have bought a combined $779.6K of CLYM across 3 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in CLYM?: A cluster buy is two or more distinct Climb Bio, Inc. insiders — officers, directors, or 10% owners — each buying CLYM on the open market within a rolling window. CLYM has 1 detected cluster buy to date.
Where does this CLYM insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in CLYM

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy CLYM within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding CLYM.